We are live on
!
Find out more
Vanguard Portfolio Management Portfolio holdings
AUM
$2.22T
This Fund
S&P 500
This Quarter
Est. Return
+25.71%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.22T
AUM Growth
+$305B
(+16%)
Cap. Flow
+$19.5B
Cap. Flow
% of AUM
0.88%
Top 10 Holdings %
Top 10 Hldgs %
21.57%
Holding
3,286
New
192
Increased
2,077
Reduced
864
Closed
145
Avg Time Held
0.9
quarters
Top 10 Avg Time Held
0.8
quarters
Top 20 Avg Time Held
0.8
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$1.74B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$1.66B |
| 3 |
NVIDIA
NVDA
|
+$1.58B |
| 4 |
Micron Technology
MU
|
+$1.23B |
| 5 |
Devon Energy
DVN
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Marvell Technology
MRVL
|
+$2.45B |
| 2 |
Seagate
STX
|
+$2.36B |
| 3 |
Western Digital
WDC
|
+$1.98B |
| 4 |
Honeywell
HON
|
+$1.74B |
| 5 |
Corning
GLW
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.19% |
| 2 | Financials | 11.67% |
| 3 | Industrials | 11.45% |
| 4 | Healthcare | 9.73% |
| 5 | Consumer Discretionary | 7.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Calumet Specialty Products
CLMT
$4.96B
| $36.9M | ﹤0.01% |
1,025,321
+95,069
| +10% | +$3.2M |
2026 Q1
1 quarter
|
|
1802
Sylvamo
SLVM
$1.3B
| $36.5M | ﹤0.01% |
965,700
-54,412
| -5% | -$2.21M |
2026 Q1
1 quarter
|
|
1803
Quanex
NX
$838M
| $36.4M | ﹤0.01% |
1,956,415
+67,824
| +4% | +$1.25M |
2026 Q1
1 quarter
|
|
|
KLRA
1804
Kailera Therapeutics
KLRA
$1.51B
| $36.4M | ﹤0.01% |
+1,652,507
| New | +$36.3M |
2026 Q2
0 quarters
|
|
1805
Nurix Therapeutics
NRIX
$2.32B
| $36M | ﹤0.01% |
1,482,861
+380,595
| +35% | +$6.48M |
2026 Q1
1 quarter
|
|
1806
Blue Bird Corp
BLBD
$1.92B
| $35.9M | ﹤0.01% |
454,852
+29,412
| +7% | +$2M |
2026 Q1
1 quarter
|
|
1807
Xencor
XNCR
$1.83B
| $35.7M | ﹤0.01% |
2,215,690
-1,284,652
| -37% | -$16M |
2026 Q1
1 quarter
|
|
|
PBLS
1808
Parabilis Medicines Inc
PBLS
$3.39B
| $35.6M | ﹤0.01% |
+1,302,479
| New | +$36M |
2026 Q2
0 quarters
|
|
|
CLDT
1809
Chatham Lodging
CLDT
$634M
| $35.6M | ﹤0.01% |
2,694,251
+24,563
| +0.9% | +$254K |
2026 Q1
1 quarter
|
|
1810
AnaptysBio
ANAB
$1.37B
| $35.6M | ﹤0.01% |
527,858
+7,988
| +2% | +$484K |
2026 Q1
1 quarter
|
|
1811
CRISPR Therapeutics
CRSP
$5.16B
| $35.4M | ﹤0.01% |
648,713
+101,887
| +19% | +$5.37M |
2026 Q1
1 quarter
|
|
|
FRMI
1812
Fermi Inc
FRMI
$2.2B
| $35.3M | ﹤0.01% |
3,852,877
+3,683,020
| +2,168% | +$23.3M |
2026 Q1
1 quarter
|
|
1813
Restaurant Brands International
QSR
$24.7B
| $35.2M | ﹤0.01% |
485,772
-27,575
| -5% | -$2.1M |
2026 Q1
1 quarter
|
|
1814
Porch Group
PRCH
$1.99B
| $35.2M | ﹤0.01% |
2,340,871
+174,017
| +8% | +$1.71M |
2026 Q1
1 quarter
|
|
|
CTO
1815
CTO Realty Growth
CTO
$768M
| $35.1M | ﹤0.01% |
1,631,242
+10,013
| +0.6% | +$203K |
2026 Q1
1 quarter
|
|
1816
ASE Group
ASX
$121B
| $35M | ﹤0.01% |
775,085
-273,371
| -26% | -$9.18M |
2026 Q1
1 quarter
|
|
1817
Evolv Technologies
EVLV
$821M
| $34.8M | ﹤0.01% |
6,002,387
+202,126
| +3% | +$1.27M |
2026 Q1
1 quarter
|
|
1818
TSMC
TSM
$2.35T
| $34.8M | ﹤0.01% |
72,859
-12,804
| -15% | -$5.2M |
2026 Q1
1 quarter
|
|
|
MRX
1819
Marex Group Limited Ordinary Shares
MRX
$5.17B
| $34.7M | ﹤0.01% |
569,895
+206,715
| +57% | +$11.4M |
2026 Q1
1 quarter
|
|
1820
Bristow Group
VTOL
$1.21B
| $34.5M | ﹤0.01% |
834,982
+2,789
| +0.3% | +$125K |
2026 Q1
1 quarter
|
|
1821
Arvinas
ARVN
$500M
| $34.3M | ﹤0.01% |
4,123,399
+233,771
| +6% | +$2.18M |
2026 Q1
1 quarter
|
|
1822
Dime Commercial Bancshares
DCOM
$1.68B
| $34.3M | ﹤0.01% |
842,900
+44,109
| +6% | +$1.64M |
2026 Q1
1 quarter
|
|
|
NIQ
1823
NIQ Global Intelligence PLC
NIQ
$5.34B
| $33.8M | ﹤0.01% |
3,615,429
+325,575
| +10% | +$3.15M |
2026 Q1
1 quarter
|
|
1824
ANI Pharmaceuticals
ANIP
$1.7B
| $33.7M | ﹤0.01% |
407,281
+31,316
| +8% | +$2.51M |
2026 Q1
1 quarter
|
|
1825
Matthews International
MATW
$581M
| $33.6M | ﹤0.01% |
1,248,196
-543,825
| -30% | -$14.6M |
2026 Q1
1 quarter
|
|
Similar funds
Vanguard Portfolio Management's Q2 2026 Portfolio in Review
As of Q2 2026, Vanguard Portfolio Management held 3,286 positions worth $2.22T, up 16% from $1.91T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Vanguard Portfolio Management's Q2 2026 filing shows 192 new, 2,077 increased, 864 reduced and 145 closed positions. Its largest new stake was SpaceX: 10,225,389 shares worth $1.75B. The largest sale was Marvell Technology, an estimated $2.45B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 29% a quarter earlier, followed by Financials and Industrials.
- Vanguard Portfolio Management's largest Q2 2026 buy was SpaceX: 10,225,389 shares worth $1.75B.
- Vanguard Portfolio Management added most to NVIDIA in Q2 2026, an estimated $1.58B increase.
- Vanguard Portfolio Management's biggest Q2 2026 reduction was Marvell Technology, cutting an estimated $2.45B.
- Vanguard Portfolio Management fully exited Coterra Energy in Q2 2026, selling an estimated $1.3B.
- Vanguard Portfolio Management's ten largest holdings make up 22% of its $2.22T portfolio in Q2 2026.
- Vanguard Portfolio Management opened 192 new positions and closed 145 in Q2 2026.
- Vanguard Portfolio Management's portfolio value rose 16% quarter-over-quarter to $2.22T.
Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.